ASTRO 2022

Questions discussed in this category

How would you treat a patient with history of stage I seminoma s/p orchiectomy with enlarging periaortic node and normal tumor markers on surveillance?

Would you biopsy lymph node to confirm recurrence/histology? If confirmed, how do you decide between RT vs chemotherapy? If chemo - BEP x3 vs E...

5 Answers available

What are your top takeaways from ASTRO 2022?

What were your “top 3” presentations/studies coming out of the meeting this year and how will it impact your own clinical prac...

8 Answers available

In light of the recent MSKCC Phase 2 data indicating reduced skeletal events with treatment, how will you approach management of patients with asymptomatic bone mets?

How will you approach patients with diffuse metastases who you would have otherwise deferred treatment? Prophylactic Radiation Therapy vs. Standard-o...

2 Answers available

Papers discussed in this category

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2012-04

Adjuvant radiation therapy for early stage seminoma: proton versus photon planning comparison and modeling of second cancer risk.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015-02-01

Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910.

International journal of radiation oncology, biology, physics, 2015-06-01

Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126.

The British journal of radiology, 2015

Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom.

International journal of radiation oncology, biology, physics, 2017-06-01

Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202.

The Lancet. Oncology, 2018-11

Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.

Int J Radiat Oncol Biol Phys, 2021 Sep 01

Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Trial.

Radiother Oncol, 2001-03-01

The impact of skin washing with water and soap during breast irradiation: a randomized study.

Lancet, 2020 Apr 28

Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.

Int J Radiat Oncol Biol Phys, 2020 Dec 13

Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial).

Clin Oncol (R Coll Radiol), 1992 Mar

Can patients wash during radiotherapy to the breast or chest wall? A randomized controlled trial.

Strahlenther Onkol, 2020 Dec 15

Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial.

Int J Radiat Oncol Biol Phys, 2021 Nov 20

Randomized Phase 3, Double-blind, Placebo-controlled Study of Prophylactic Gabapentin for the Reduction of Oral Mucositis Pain During the Treatment of Oropharyngeal Squamous Cell Carcinoma.

Radiother Oncol, 2020 Aug 06

First experience with model-based selection of head and neck cancer patients for proton therapy.

J Clin Med, 2022 Aug 19

Pharmacological Management of Neuropathic Pain after Radiotherapy in Head and Neck Cancer Patients: A Systematic Review.

Lancet Oncol,

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

Clin Transl Radiat Oncol, 2022 Oct 13

Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial.

ASTRO 2022

Questions discussed in this category

Papers discussed in this category

Related Topics